Concepedia

Mary McCauley

MM

Statistics

Publications

8

Citations

409

H-Index

8

Active since

1994

Affiliations

Dana-Farber Cancer Institute(Current)

Beth Israel Deaconess Hospital

Harvard University

University of Rochester

Mary McCauley is an author at Dana-Farber Cancer Institute specializing in radiation oncology, transplantation, and cell transplantation.

Top concepts

Publications per year

1994–2004

8

Publications

8

Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-α/β–inducible gene expression, without significant toxicity

Jonathan W. Friedberg, Helen Kim, Mary McCauley et al. · Blood · 2004 · 151 citations · Full text

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Catherine Wheeler, Christiane Eickhoff, AD Elias et al. · PubMed · 1997 · 59 citations

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Anthony Elias, Joseph Ibrahim, Arthur T. Skarin et al. · Journal of Clinical Oncology · 1999 · 53 citations

Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease

Jonathan W. Friedberg, Donna Neuberg, Helen Kim et al. · Cancer · 2003 · 52 citations · Full text

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.

Alby Elias, Lois Ayash, Catherine Wheeler et al. · PubMed · 1995 · 36 citations

1–5 of 8